Cited by

• Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism.

  Lambert PW, Heath H 3rd, Sizemore GW. Lambert PW, et al. J Clin Invest. 1979 Apr;63(4):602-8. doi: 10.1172/JCI109342. J Clin Invest. 1979. PMID: 438324 Free PMC article.
• The Diagnostic Accuracy of Procalcitonin, Soluble Urokinase-Type Plasminogen Activator Receptors, and C-Reactive Protein in Diagnosing Urinary Tract Infections in the Emergency Department-A Diagnostic Accuracy Study.

  Hertz MA, Johansen IS, Rosenvinge FS, Brasen CL, Andersen ES, Heltborg A, Skovsted TA, Petersen ERB, Cartuliares MB, Nielsen SL, Mogensen CB, Skjøt-Arkil H. Hertz MA, et al. J Clin Med. 2024 Mar 20;13(6):1776. doi: 10.3390/jcm13061776. J Clin Med. 2024. PMID: 38542009 Free PMC article.
• Infective Complications of Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) and Clinical Biomarkers: A Concise Review.

  Bosgana P, Ampazis D, Vlachakos V, Tzouvelekis A, Sampsonas F. Bosgana P, et al. Diagnostics (Basel). 2025 Jan 9;15(2):145. doi: 10.3390/diagnostics15020145. Diagnostics (Basel). 2025. PMID: 39857029 Free PMC article. Review.
• Calcitonin heterogeneity: in vivo and in vitro studies.

  Roos BA, Parthemore JG, Lee JC, Deftos LJ. Roos BA, et al. Calcif Tissue Res. 1977 May;22 Suppl:298-302. doi: 10.1007/BF02064083. Calcif Tissue Res. 1977. PMID: 199331 No abstract available.
• New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.

  Price PA, Parthemore JG, Deftos LJ. Price PA, et al. J Clin Invest. 1980 Nov;66(5):878-83. doi: 10.1172/JCI109954. J Clin Invest. 1980. PMID: 6968755 Free PMC article.